Former CTO of Integer, joins AdvaStim to expand alliance partnerships and commercialization opportunities BOSTON--(BUSINESS WIRE)--AdvaStim, Inc., www.advastim.com, a leading developer of ASIC-based technology platforms for neuromodulation therapies, announced...Read More »
Advanced Technology Platforms for Neuromodulation Therapy Developers
AdvaStim is addressing the $3+ Billion neurostimulation market with a disruptive hardware/software technology platform, along with industry-leading design and manufacturing resources, to help emerging device companies effectively implement the next generation of implantable device therapeutics.
AdvaStim’s ASICoreTM technology is a state-of-the-art, VLSI-based chip architecture providing groundbreaking capabilities for multi-channel switching and electrode programming, all adaptable to the industry’s shrinking form factors. AdvaStim’s ASIControlTM embedded software gives therapy developers complete customization of output parameters for advanced waveform modes. These technologies, combined with our AdvaStim-XTM neurosystems design and manufacturing partnerships, give neurostimulator device developers a trusted domestic source to bring their imagined therapy solutions to reality.
AdvaStim’s technology platforms give developers the ability to shape the stimulation field through independent pulse generator channels and provides tools to allow them to explore the issue of neural adaptation. AdvaStim’s modular system architecture provides a building-block approach for cost-effective, easy customization to a variety of clinical indications.
Evergreen Medical Technologies Quadruples Size of Cleanroom Manufacturing Space for Implantable Medical Devices
Expanded ISO Class 7 and Class 8 Cleanroom Facilities Allow for Single-Source Manufacturing of Active Implantable Medical DevicesSAINT PAUL, Minnesota, January 11, 2017: Evergreen Medical Technologies,...Read More »